MedPath
FDA Approval

Brim-Dor PF

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
ImprimisRx NJ
DUNS: 931390178
Effective Date
May 8, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Brimonidine(1.5 mg in 1 mL)
Dorzolamide(20 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Brim-Dor PF

Product Details

NDC Product Code
70261-518
Route of Administration
OPHTHALMIC
Effective Date
May 8, 2018
Code: 4S9CL2DY2HClass: ACTIMQuantity: 1.5 mg in 1 mL
Code: QZO5366EW7Class: ACTIMQuantity: 20 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath